[Lysophosphatidic acid: a "bioactive" phospholipid].
Lysophosphatidic acid (LPA) is a "bioactive" phospholipid able to generate growth factor-like activities in a wide variety of normal and malignant cell types. LPA is proposed to play an important role in normal physiological situations such as wound healing, vascular tone, vascular integrity, or reproduction. In parallel, LPA could also be involved in the etiology of some diseases such as atherosclerosis, cancer, or obesity. The bioactivity of LPA is mediated by the activation of specific G-protein coupled receptors (LPA1, LPA2, and LPA3) leading to the activation of a number of intracellular effectors. LPA is present in solution (bound to albumin) in various extracellular fluids (blood, ascites, aqueous humor), and is released in vitro by some cell types such as platelets, cancer cells, or adipocytes. LPA is a rather polar phospholipid, which cannot easily diffuse throughout plasma membrane, and its presence outside the cells requires soluble phospholipases (secreted phospholipase A2 and soluble lysophospholipase D/autotaxin), which synthesize LPA directly in the extracellular milieu, from precursors such as phosphatidic acid and lysophosphatidylcholine. In the future, LPA receptors, as well as the enzymes involved in LPA metabolism, will constitute promising pharmacological and transgenic targets to determine the physiopathological relevance of "bioactive" LPA in vivo.
Saulnier-Blache
Jean-Sébastien
JS
Inserm U.586, Institut Louis Bugnard, CHU Rangueil, 31404 Toulouse, France. saulnier@toulouse.inserm.fr
D000818:Animals; D004194:Disease / Q000209:etiology; D006801:Humans; D008246:Lysophospholipids / Q000378:metabolism / Q000502:physiology*; D049368:Receptors, Lysophosphatidic Acid / Q000502:physiology
D008246:Lysophospholipids; D049368:Receptors, Lysophosphatidic Acid